Sangreal Spółka z Ograniczoną Odpowiedzialnością (KRS 0000685259, NIP 8792693306) is a Polish company, headquartered in Grabowiec, Kujawsko-Pomorskie voivodeship. SANGREAL operates in: Retail sale of clothing in specialised stores (PKD 47.71.Z). Industry: Retail trade. The company has been listed in the National Court Register since July 4, 2017.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Sangreal
Identity
- Name
- Sangreal Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- July 4, 2017
- Registry status as of
- July 10, 2026
- Latest entry
- July 10, 2026
- Founding act
- 10.02.2017 R.; REP. A NR 539/2017; NOTARIUSZ ŁUKASZ CHWIAŁKOWSKI; KANCELARIA NOTARIALNA W TORUINIU PRZY ULICY ŁAZIENNEJ …
Articles of association history (1)
- February 10, 2017: 10.02.2017 R.; REP. A NR 539/2017; NOTARIUSZ ŁUKASZ CHWIAŁKOWSKI; KANCELARIA NOTARIALNA W TORUINIU PRZY ULICY ŁAZIENNEJ NR 32
Activities
Main activity
47.71.ZRetail sale of clothing in specialised stores
Other activities
Address and contact
- Address
- UL. RADOSNA, 15, 87-162, GRABOWIEC, POLSKA
- Voivodeship
- KUJAWSKO-POMORSKIE
- District
- TORUŃSKI
- CONTACT@SANGREAL.CO
- Website
- WWW.SANGREAL.CO
- E-delivery address
- Not disclosed in the registry
Risk and payment profile - Sangreal
Credibility rating
60.5 / 100
Good credibility
Insolvency risk
Very low
Low threat
Closure risk
1
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
0
0/9 yrs
Board changes
0
0/9 yrs
PKD changes
0
0/9 yrs
Name changes
0
0/9 yrs
Data from 9 years of registry activity.
Credibility history
Payment reliability score from 2018–2024
Current: C (61/100)
Trend: stable (0.0 pts/year)
Moderate payment credibility - the company is able to meet its obligations, but some indicators warrant caution.
Trade credit limit history
Standard limit from 2018–2024
Current: 900 PLN
Safe: 405 PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Sangreal
Founded
July 4, 2017
9 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
GRABOWIEC
KUJAWSKO-POMORSKIE
Primary PKD
47.71.Z
Retail sale of clothing in specialised stores
Share capital
5.0 K PLN
50 shares total
Shareholders
2
shareholders
Board
2 people
Filed years
7 years
2018–2024
Registry entries
27
latest: July 10, 2026
Revenue
N/A
2024
Net profit
N/A
2024
Assets
5.0 K PLN
2024
Equity
5.0 K PLN
2024
Valuation
4.3 K PLN
Low confidence
Low confidence
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Sangreal.
No ratings
Related articles
News
Ambra in 2026: PLN 48.1 m capex (+212%), PLN 1.10 dividend three years running, Cydr Lubelski plus Romanian Zarea as the premium engine
Warsaw-based Ambra S.A. (KRS 0000041726, ul. Puławska 336) closed H1 of fiscal 2025/2026 with PLN 556.8 m of revenue and PLN 49.0 m of net profit, while raising capex by 212% to PLN 48.1 m - mainly for the soft-drinks line in Wola Duża and the PLN 11.9 m acquisition of a Romanian company. Despite the aggressive investment cycle the board keeps a PLN 1.10 dividend per share for the third year running (~5.9% yield).
News
Answear in 2026: first full year without MCI, PLN 9.3 m net profit, but the supervisory board cuts the 2026 EBITDA target from PLN 100 m to PLN 90 m
Kraków-based Answear.com S.A. (KRS 0000816066) closed 2025 with revenue of PLN 1.7 bn (+13% YoY), EBITDA of PLN 56 m (+63%) and net profit of PLN 9.3 m - a return to the black after a PLN 10 m loss in 2024. Poland grew +31%, but CEE was under FX pressure (hryvnia -11% vs PLN), and a weak Q4 (EBITDA -71% YoY) forced the supervisory board to cut the 2026 EBITDA target from PLN 100 m to PLN 90 m and the target price from PLN 50 to PLN 45. It is the first full year after MCI's exit from the shareholder base (10 June 2025); the Bajołek brothers retain control (57.8%).
